Female Urology

Urology Associates of North Texas (UANT) has agreed to merge with a six-physician urology group in Forth Worth.

Caxias do Sul, Brazil--Men over the age of 40 years may have lower semen quality, but not necessarily lower sperm morphology. That's an important fact to remember when evaluating these men for infertility, suggests a study by Brazilian researchers.

Interstitial cystitis is not an uncommon condition, yet researchers continue in their struggle to define it and reach consensus on appropriate diagnostic criteria. In part one of this two-part Urology Times interview, Christopher K. Payne, MD, discusses the current controversy over the definition of IC and his approach to diagnosis.

Interstitial cystitis is not an uncommon condition, yet researchers continue in their struggle to define it and reach consensus on appropriate diagnostic criteria. In part one of this two-part Urology Times interview, Christopher K. Payne, MD, discusses the current controversy over the definition of IC and his approach to diagnosis.

Nearly one-half of in vitro fertilization cycles are conducted using intracytoplasmic sperm injection.

Postmenopausal women who are Hispanic, obese, and/or diabetic appear to be at higher risk for urogenital symptoms, according to findings from a large study.

Postmenopausal women who are Hispanic, obese, and/or diabetic appear to be at higher risk for urogenital symptoms, according to findings from a large study.

San Diego-Treatment with the dual neurotransmitter reuptake inhibitor duloxetine (Yentreve) results in durable improvement in symptoms of stress urinary incontinence, according to a study of open-label transition from placebo to active therapy.

San Diego-Two anticholinergic drugs commonly used in the treatment of overactive bladder have similarly low incidences of adverse events affecting the central nervous system, according to an analysis of data from a large randomized trial of the agents.

San Diego-Treatment with the dual neurotransmitter reuptake inhibitor duloxetine (Yentreve) results in durable improvement in symptoms of stress urinary incontinence, according to a study of open-label transition from placebo to active therapy.

San Diego--Two large studies have arrived at very different conclusions about the value of routine urine cytology and cystoscopy for evaluating women presenting with irritative voiding symptoms.

An investigational testosterone transdermal patch (Intrinsa) increases sexual activity and desire and decreases personal distress in women with hypoactive sexual desire disorder, according to study results presented at the North American Menopause Society annual meeting.

San Diego-A newer bulking agent consisting of synthetic calcium hydroxylapatite compares favorably with traditional glutaraldehyde cross-linked bovine collagen as a treatment for type III stress urinary incontinence or intrinsic sphincteric deficiency, according to an interim analysis of data from an ongoing randomized trial of the two substances.

San Diego--In a comparison of sling materials for sacral colpopexy, polypropylene mesh met the challenge of solvent-dehydrated cadaveric fascia lata and demonstrated a statistically significant outcome advantage at 1 year, University of Louisville (KY) researchers reported.

Revisions have been made to the precautions and adverse reactions sections of the label for the bisphosphonate zoledronic acid (Zometa).

San Francisco--Urinary incontinence remains a common medical condition in older women, even in those who rate their health as "good" or "excellent." Nearly 12% of elderly women experience stress, urge, or other form of incontinence, according to findings from an analysis of the Health, Aging, and Body Composition study published in Obstetrics & Gynecology (2004; 104:301-7). The condition is more prevalent in Caucasian women than in African-Americans, the study found.

San Francisco--Urinary incontinence remains a common medical condition in older women, even in those who rate their health as "good" or "excellent." Nearly 12% of elderly women experience stress, urge, or other form of incontinence, according to findings from an analysis of the Health, Aging, and Body Composition study published in Obstetrics & Gynecology (2004; 104:301-7). The condition is more prevalent in Caucasian women than in African-Americans, the study found.

A 6-month course of androgen suppression therapy following radiation treatment for clinically localized prostate cancer confers survival benefits similar to those seen with longer courses of androgen blockade (>3 years), according to a recent study from Brigham and Women's Hospital and the Dana Farber Cancer Institute, Boston. The study also suggests that only partial blockade with a luteinizing hormone-releasing hormone (LHRH) agonist may be sufficient.

Tel Aviv, Israel--Twin pregnancy per se, with no trial of labor, increases the risk of postpartum stress urinary incontinence, according to a prospective study by obstetrician-gynecologists from Tel Aviv University, Israel.

Toronto--Patients who show evidence of rare non-motile sperm after undergoing vasectomy will eventually become azoospermic-marking vasectomy success. However, patient compliance post-vasectomy remains low, despite aggressive pre- and postoperative counseling, University of Toronto researchers report.

The majority of testicular tumors identified during the course of an infertility examination would not otherwise have been found at that stage, according to urologists from Tel Aviv University in Israel.

San Francisco--As a salvage for locally recurrent prostate cancer after failed radiation, targeted cryoablation of the prostate (TCAP) provides a "significantly better overall quality of life" than salvage radical prostatectomy, said Aaron E. Katz, MD, at the AUA annual meeting.

San Francisco--Once infection has been ruled out as a cause of a man's pelvic pain, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is the diagnosis. Although a symptom and problem index is available to help clinicians and researchers follow the patient's progress, there is no objective test that helps clinch a diagnosis, define the extent of disease, or measure its progression or regression.

New Orleans--Data from a randomized clinical trial show that long-term treatment with the bisphosphonate agent zoledronic acid (Zometa) halved the rate of skeletal events in patients with advanced prostate cancer and bone metastases.

Dextranomer/hyaluronic acid has the potential to lower the cost and also the morbidity of repeated voiding cystourethrograms in children.